In multivariate survival analysis (Cox regression with the forward step procedures), the methylated status of CpG −232 of the ZNF545 promoter was considered as an independent prognostic predictor of 158 patients with GC, indicating the importance of ZNF545 promoter methylation. Here, ZFP82 is linked to gastric cancer.